Diazald-d3
CAS: 42366-72-3
Ref. 3D-SBA36672
| 1g | Ausgelaufen | ||
| 10mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen | ||
| 250mg | Ausgelaufen | ||
| 500mg | Ausgelaufen |
Produktinformation
Name:
Diazald-d3
Synonyme:
- 4-Methyl-N-(methyl-d<sub>3</sub>)-N-nitrosobenzenesulfonamide
- Benzenesulfonamide, 4-methyl-N-(methyl-d<sub>3</sub>)-N-nitroso-
- Diazald(R)-N-Methyl-D3
- Diazald-N-Methyl-D3, 98 Atom % D
- Diazald?N-methyl-d3
- N-Methyl-D3-N-Nitroso-P-Toluenesulfonamide
- N-Methyl-N-Nitroso-P-Toluenesulfonamide (N-Methyl-D3)
- p-Toluenesulfonamide, N-methyl-d<sub>3</sub>-N-nitroso-
Beschreibung:
Diazald-d3 is a potent inhibitor of cancer cell growth and a promising medicinal compound for the treatment of various types of cancer. It targets human kinases involved in the regulation of the cell cycle, which are often overexpressed in tumor cells. Diazald-d3 has been shown to induce apoptosis and inhibit proliferation in several cancer cell lines, making it a potential anticancer agent. In addition, recent studies suggest that Diazald-d3 can be effectively delivered to cancer cells using nanoparticles, increasing its therapeutic potential. With its ability to target key proteins involved in cancer development and progression, Diazald-d3 represents a promising avenue for the development of novel cancer therapies.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
217.26 g/mol
Formel:
C8H10N2O3S
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
